- Around two million people in England and Scotland are experiencing symptoms of long COVID, with 1.5 million reporting interference with day-to-day activities.
- Research shows overlaps between long COVID and ME/CFS, a condition characterized by severe fatigue, pain, and cognitive issues, affecting around 250,000 in the UK and 2 million in the EU.
- Studies are underway to explore the role of viral reactivation, mitochondrial dysfunction, gut dysbiosis, and genetic factors in ME/CFS.
- Promising research into treatments such as antiviral drugs and red light therapy is providing hope for improving symptoms of ME/CFS.
- Despite progress in ME/CFS research, lack of funding remains a challenge, with calls for increased government support to address the disparity in funding compared to other conditions.
Source link
Internal Medicine, Pulmonary Medicine